A first-in-class anticancer dual HDAC2/FAK inhibitors bearing hydroxamates/benzamides capped by pyridinyl-1,2,4-triazoles - Concepedia

Concepedia

Publication | Open Access

A first-in-class anticancer dual HDAC2/FAK inhibitors bearing hydroxamates/benzamides capped by pyridinyl-1,2,4-triazoles

DOI Full Paper Access

40

Citations

37

References

2021

Year

Muhamad Mustafa, Amer Ali Abd El‐Hafeez, Dalia Abdelhamid, Gajanan D. Katkar, Yaser A. Mostafa, Pradipta Ghosh, Alaa M. Hayallah, Gamal El‐Din A. Abuo‐Rahma

European Journal of Medicinal Chemistry

Combinatorial ChemistryMedicinal ChemistryMedicinePharmacological AgentPharmacotherapyAnti-cancer AgentPharmacologyRadiation OncologyPharmaceutical ChemistryDrug Discovery

References

	Year	Citations

Page 1

Page 1